Skip to main content

Cannabis Canadian cannabis firm Origin House bought by U.S. company for $1.1-billion

Part of cannabis and investing

Canadian cannabis branding company Origin House has entered into an agreement to be acquired by U.S. company Cresco Labs Inc. for approximately $1.1 billion.

As part of the all-stock deal, Origin House common shareholders will receive 0.8428 subordinate voting shares of Cresco, a cannabis cultivator, processor and retailer headquartered in Chicago, for each share of the Ottawa-based pot firm.

The two companies say in a joint release that the deal amounts to approximately $1.1 billion on a fully-diluted basis, or $12.68 per Origin House share based on Cresco’s closing price on March 29.

Story continues below advertisement

Origin House, previously known as CannaRoyalty, has a portfolio of more than 50 brands including Chong’s Choice and Cheech’s Favourite Stash by cannabis comic Tommy Chong.

Origin House’s brands and 130 branded products are distributed to more than 500 dispensaries across California, where recreational cannabis is legal and a key market for U.S. operators.

The companies say the resulting combined entity will be one of the largest, vertically integrated multi-state operators south of the border.

Available now: Cannabis Professional, the authoritative e-mail newsletter tailored specifically for professionals in the rapidly evolving cannabis industry. Subscribe now.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Discussion loading ...

Cannabis pro newsletter